Statistics for Safety of Tumor Necrosis Factor Inhibitor Use in Patients with Concomitant Malignancy
Total visits
views | |
---|---|
Safety of Tumor Necrosis Factor Inhibitor Use in Patients with Concomitant Malignancy | 114 |
Total visits per month
views | |
---|---|
November 2023 | 0 |
December 2023 | 0 |
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
File Visits
views | |
---|---|
Phan, H.pdf | 29 |
Top country views
views | |
---|---|
United States | 55 |
Germany | 12 |
Ireland | 9 |
China | 8 |
Russia | 7 |
Finland | 6 |
Hong Kong SAR China | 3 |
Czechia | 2 |
Poland | 2 |
Sweden | 2 |
Canada | 1 |
United Kingdom | 1 |
Israel | 1 |
Japan | 1 |
South Korea | 1 |
Lithuania | 1 |
New Zealand | 1 |
Taiwan | 1 |
Top city views
views | |
---|---|
Dallas | 9 |
Dublin | 9 |
Council Bluffs | 3 |
Des Moines | 3 |
Houston | 3 |
Gorzyce | 2 |
Beijing | 1 |
Boardman | 1 |
Brooklyn | 1 |
Buffalo | 1 |
Cambridge | 1 |
Chandler | 1 |
Dunedin | 1 |
Durham | 1 |
Elyria | 1 |
Geisenhausen | 1 |
Gimcheon | 1 |
Hefei | 1 |
Heidelberg | 1 |
Hsinchu | 1 |
Kaunas | 1 |
Kyoto | 1 |
Old Bridge | 1 |
Philadelphia | 1 |
Plano | 1 |
Sherwood | 1 |